Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 677.25
(3.59%)
INR 677.25
(3.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 724.71 Million INR | 0.14% |
| 2022 | 560.72 Million INR | 49.62% |
| 2021 | 374.76 Million INR | 53.19% |
| 2020 | 244.63 Million INR | -4.66% |
| 2019 | 256.58 Million INR | -18.52% |
| 2018 | 314.89 Million INR | 82.49% |
| 2017 | 172.55 Million INR | 13.38% |
| 2016 | 152.18 Million INR | 20.2% |
| 2015 | 126.61 Million INR | 48.41% |
| 2014 | 85.31 Million INR | 57.12% |
| 2013 | 54.29 Million INR | 8.05% |
| 2012 | 50.25 Million INR | 70.8% |
| 2011 | 29.42 Million INR | -33.93% |
| 2010 | 44.53 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 138.3 Million INR | -27.74% |
| 2023 FY | 561.48 Million INR | 0.14% |
| 2023 Q4 | 191.39 Million INR | 18.25% |
| 2023 Q3 | 161.85 Million INR | 5.66% |
| 2023 Q2 | 153.17 Million INR | 13.33% |
| 2023 Q1 | 135.16 Million INR | -68.31% |
| 2022 FY | 560.72 Million INR | 49.62% |
| 2022 Q4 | 426.58 Million INR | 218.02% |
| 2022 Q2 | 119.67 Million INR | 36.1% |
| 2022 Q1 | 87.93 Million INR | -34.02% |
| 2022 Q3 | 134.13 Million INR | 12.09% |
| 2021 Q1 | 55.99 Million INR | -42.93% |
| 2021 FY | 374.76 Million INR | 53.19% |
| 2021 Q4 | 133.27 Million INR | 41.64% |
| 2021 Q3 | 94.09 Million INR | 2.95% |
| 2021 Q2 | 91.39 Million INR | 63.21% |
| 2020 Q4 | 98.12 Million INR | 48.9% |
| 2020 Q1 | 35.73 Million INR | -66.14% |
| 2020 FY | 244.63 Million INR | -4.66% |
| 2020 Q2 | 67.51 Million INR | 88.91% |
| 2020 Q3 | 65.9 Million INR | -2.39% |
| 2019 Q1 | 54.6 Million INR | -46.48% |
| 2019 FY | 256.58 Million INR | -18.52% |
| 2019 Q2 | 46.55 Million INR | -14.75% |
| 2019 Q3 | 50.89 Million INR | 9.33% |
| 2019 Q4 | 105.53 Million INR | 107.35% |
| 2018 Q4 | 102.03 Million INR | 26.19% |
| 2018 FY | 314.89 Million INR | 82.49% |
| 2018 Q3 | 80.85 Million INR | -4.0% |
| 2018 Q2 | 84.22 Million INR | 100.87% |
| 2018 Q1 | 41.92 Million INR | -39.07% |
| 2017 FY | 172.55 Million INR | 13.38% |
| 2017 Q1 | 32.97 Million INR | -50.66% |
| 2017 Q2 | 42.7 Million INR | 29.5% |
| 2017 Q3 | 41.08 Million INR | -3.79% |
| 2017 Q4 | 68.81 Million INR | 67.5% |
| 2016 FY | 152.18 Million INR | 20.2% |
| 2016 Q3 | 38.45 Million INR | -20.68% |
| 2016 Q2 | 48.48 Million INR | 17.07% |
| 2016 Q1 | 41.41 Million INR | -35.4% |
| 2016 Q4 | 66.83 Million INR | 73.81% |
| 2015 Q1 | 28.44 Million INR | 496.72% |
| 2015 FY | 126.61 Million INR | 48.41% |
| 2015 Q4 | 64.1 Million INR | 76.08% |
| 2015 Q3 | 36.4 Million INR | 40.3% |
| 2015 Q2 | 25.94 Million INR | -8.76% |
| 2014 Q2 | 27.86 Million INR | 30.43% |
| 2014 Q1 | 21.36 Million INR | 427.86% |
| 2014 FY | 85.31 Million INR | 57.12% |
| 2014 Q4 | -7.16 Million INR | -139.78% |
| 2014 Q3 | 18.02 Million INR | -35.33% |
| 2013 Q1 | 17.21 Million INR | 208.99% |
| 2013 FY | 54.29 Million INR | 8.05% |
| 2013 Q3 | 24.56 Million INR | -28.5% |
| 2013 Q2 | 34.35 Million INR | 99.49% |
| 2013 Q4 | -6.51 Million INR | -126.53% |
| 2012 Q4 | -15.79 Million INR | -151.91% |
| 2012 FY | 50.25 Million INR | 70.8% |
| 2012 Q3 | 30.43 Million INR | 67.56% |
| 2012 Q2 | 18.16 Million INR | 4.07% |
| 2012 Q1 | 17.45 Million INR | 0.0% |
| 2011 FY | 29.42 Million INR | -33.93% |
| 2010 FY | 44.53 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 331.34 Million INR | -118.722% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 43.476% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -1761.056% |
| MedPlus Health Services Limited | 12.33 Billion INR | 94.123% |
| ANG Lifesciences India Limited | 232.73 Million INR | -211.393% |
| Add-Shop E-Retail Limited | 224.09 Million INR | -223.393% |
| Bacil Pharma Limited | -19.95 Thousand INR | 3632751.629% |
| BDH Industries Limited | 175.55 Million INR | -312.813% |
| Beryl Drugs Limited | 108.5 Million INR | -567.921% |
| Cian Healthcare Limited | 113.16 Million INR | -540.388% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -3842.52% |
| Concord Drugs Limited | 116.7 Million INR | -520.985% |
| Deccan Health Care Limited | 221.57 Million INR | -227.08% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | -412.495% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -22978.285% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 34.61% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | -548.432% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 49.567% |
| Makers Laboratories Limited | 308.54 Million INR | -134.88% |
| Medi-Caps Limited | 68.09 Million INR | -964.316% |
| Panchsheel Organics Limited | 356.44 Million INR | -103.315% |
| Parmax Pharma Limited | 99.31 Million INR | -629.697% |
| Parnax Lab Limited | 552.1 Million INR | -31.263% |
| Patidar Buildcon Limited | -26 Thousand INR | 2787461.538% |
| Phaarmasia Limited | 38.89 Million INR | -1763.497% |
| Vikram Thermo (India) Limited | 443.73 Million INR | -63.322% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -246.956% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 178600.985% |
| Smruthi Organics Limited | 324.76 Million INR | -123.153% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | -997.852% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | -100.325% |
| Trident Lifeline Limited | 119.08 Million INR | -508.584% |
| Transchem Limited | -8.96 Million INR | 8182.912% |
| Trinity League India Limited | 1.23 Million INR | -58724.188% |
| Tyche Industries Limited | 290.84 Million INR | -149.174% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -7132.675% |
| Vivanza Biosciences Limited | 19.38 Million INR | -3638.144% |
| PRAVEG LIMITED | 266.99 Million INR | -171.435% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 39.583% |
| Sunil Healthcare Limited | 247.86 Million INR | -192.381% |
| Syschem (India) Limited | 569.04 Million INR | -27.356% |
| Zenith Healthcare Limited | 46.17 Million INR | -1469.528% |
| Zenlabs Ethica Limited | 147.75 Million INR | -390.487% |
| Mercury Laboratories Limited | 279.39 Million INR | -159.392% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | -553.066% |
| Vasundhara Rasayans Limited | 207.68 Million INR | -248.952% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 594.092% |
| Roopa Industries Limited | 72.95 Million INR | -893.398% |
| PANJON LTD. | 33.77 Million INR | -2045.457% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 1095.24% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 4169.141% |
| Anuh Pharma Limited | 1.6 Billion INR | 54.802% |
| Crestchem Limited | 51.53 Million INR | -1306.184% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 9849.953% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | -108.788% |
| Trimurthi Limited | 1.95 Million INR | -37045.771% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | -141.261% |
| Norris Medicines Limited | 29.36 Million INR | -2368.177% |
| Veerhealth Care Limited | 49.57 Million INR | -1361.883% |
| Lactose (India) Limited | 230.3 Million INR | -214.67% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 826.225% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | -0.986% |
| Gennex Laboratories Limited | 276.99 Million INR | -161.634% |
| Denis Chem Lab Limited | 596.24 Million INR | -21.546% |
| Colinz Laboratories Limited | 16.35 Million INR | -4331.146% |
| Godavari Drugs Limited | 359.01 Million INR | -101.865% |
| Zenotech Laboratories Limited | 337.19 Million INR | -114.922% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | -7.496% |
| Bharat Parenterals Limited | 989.46 Million INR | 26.757% |
| Coral Laboratories Limited | 332.39 Million INR | -118.03% |
| Evoq Remedies Limited | 47.43 Million INR | -1427.837% |
| Kerala Ayurveda Limited | 447.69 Million INR | -61.878% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 1880.012% |
| Natural Capsules Limited | 557.1 Million INR | -30.087% |
| Auro Laboratories Limited | 249.39 Million INR | -190.595% |